Daniel Marcel Legault, Chief Executive Officer at Antibe Therapeutics, holds 671.67K shares in Antibe Therapeutics (Ticker: ATBPF). Most recently, Daniel Marcel Legault Bought $75,000 shares of Antibe Therapeutics on Sep 25, 2020 for an estimated value of 25.50K.